ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,745.37
0.00%
Dow Jones
42,175.11
0.00%
US Dollar vs MXN
19.59446
-0.15%
Brent Oil
70.965
0.02%
Bitcoin
65,800.02
0.94%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
27/09/202408:01Edgar (US Regulatory)Form 8-K - Current reportNYSE:MLNKMeridianLink Inc
27/09/202408:01GlobeNewswire Inc.Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal SprayNASDAQ:CYTOAltamira Therapeutics Ltd
27/09/202408:00GlobeNewswire Inc.Hammond Power Solutions Closes $65.5 Million Bought Deal Secondary OfferingHPS-A
27/09/202408:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LXEHLixiang Education Holding Company Ltd
27/09/202408:00Edgar (US Regulatory)Form 424B1 - Prospectus [Rule 424(b)(1)]NASDAQ:BNZIWBanzai International Inc
27/09/202408:00Business WireNext Health Announces Proactive Healthcare and Longevity Centers Coming Soon to Tampa and St. Petersburg
27/09/202408:00Business WireLEO Pharma Presents Late-breaking Tralokinumab Data at EADV 2024 for Moderate-to-Severe Atopic Dermatitis (AD) in the Difficult-to-Treat Head and Neck Region
27/09/202408:00GlobeNewswire Inc.Capital Power to release third quarter 2024 results on October 30CPX-PC
27/09/202408:00Business WireQuantum Health Appoints Fares Alraie as Chief Technology Officer to Enhance Company’s Generative AI Platform, Operational Scale and Member Journey Mapping Technology
27/09/202408:00Business WireAllied Gaming & Entertainment Acknowledges Public Filing Release by Company ShareholderNASDAQ:AGAEAllied Gaming and Entertainment Inc
27/09/202408:00Business WireColbeck Capital Management Sponsors Annual Homes with Hope Comedy Event
27/09/202408:00GlobeNewswire Inc.PRIDE Industries Named a 2024 Leading Disability Employer by the National Organization on Disability
27/09/202408:00Business WireEntrata Announces New Lineup of ELI+ Product Suites at the 11th Annual Entrata Summit 2024
27/09/202408:00Business WireNew York Life Investments Announces Changes to ETF Lineup
27/09/202408:00GlobeNewswire Inc.Color Star Technology Announces Pricing of Initial $7.0 Million Tranche of up to $33.0 Million Registered Senior Secured Convertible NotesNASDAQ:ADDColor Star Technology Company Ltd
27/09/202408:00GlobeNewswire Inc.Affordable Signature Locksmith is Now Value Signature Locksmith: Same Trusted Service with a New Name
27/09/202408:00GlobeNewswire Inc.HotelPlanner Announces Senior Management Advancements
27/09/202408:00Business WireCurtiss-Wright to Announce Third Quarter 2024 Financial ResultsNYSE:CWCurtiss Wright Corp
27/09/202408:00Business WireSusan G. Komen® to Host MORE THAN PINK Walk in Austin this Fall
27/09/202408:00Business WireIambic Therapeutics Named to the Endpoints 11 List of Biotech’s Most Promising Startups
27/09/202408:00GlobeNewswire Inc.Turning Point of Tampa Now In-Network with Blue Cross Blue Shield Insurance
27/09/202408:00Business WireJoyce University Launches Accelerated Three-Year Bachelor’s Pathway in Arizona
27/09/202408:00GlobeNewswire Inc.Late-Breaking Data at EADV of ESK-001, an Oral TYK2 Inhibitor for the Treatment of Psoriasis, Demonstrate Significant Responses with Sustained Increases Over 28 Weeks in Phase 2 OLE StudyNASDAQ:ALMSAlumis Inc
27/09/202408:00Business WireThe Magazine ANTIQUES Broadcasts Two-Part Podcast Interview With Claremont Rug Company
27/09/202408:00Business WireTennant Company Announces New Approach to Corporate Giving and 2024 Habitat for Humanity Carter Work Project SponsorshipNYSE:TNCTennant Co
27/09/202408:00PR Newswire (US)Why Did a Canadian CEO Found His Electric Motorcycle Business in China?
27/09/202408:00PR Newswire (US)DHL Express Announces Annual Price Adjustments in the U.S.
27/09/202408:00PR Newswire (US)E-Verify Desk Reviews Made Easy with OnBlick's Guidance
27/09/202408:00PR Newswire (Canada)Funding for First Nations Guardians now managed by world's first Indigenous-led national stewardship network
27/09/202408:00PR Newswire (US)Survey Finds America's Workers Wary of AI Use in Payroll Management

Su Consulta Reciente

NASDAQ
AMZN
Amazon.com
NASDAQ
MSFT
Microsoft
COIN
AVAXUSD
Avalanche
CCOM
SILVER
SILVER
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
NKE
Nike
NYSE
CVX
Chevron
NYSE
MCD
McDonalds
AMEX
SPY
SPDR S&P 500
NYSE
JPM
JP Morgan Chase
COIN
XRPUSD
Ripple
AMEX
XLE
Energy Select Sector SPDR
AMEX
XLV
Health Care Select Sector
COIN
ADAUSD
Cardano
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados